Amiloride (MK-870), a new antikaluretic diuretic. Comparison to other antikaluretic diuretics in patients with liver disease and ascites.
D000136:Acid-Base Equilibrium; D000578:Amidines / Q000009:adverse effects / Q000627:therapeutic use; D001201:Ascites / Q000188:drug therapy*; D001344:Autopsy; D002277:Carcinoma / Q000188:drug therapy; D004232:Diuretics / Q000009:adverse effects / Q000627:therapeutic use*; D004976:Ethacrynic Acid / Q000627:therapeutic use; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006863:Hydrogen-Ion Concentration; D006947:Hyperkalemia / Q000139:chemically induced; D008103:Liver Cirrhosis / Q000188:drug therapy*; D008113:Liver Neoplasms / Q000188:drug therapy; D011719:Pyrazines / Q000009:adverse effects / Q000627:therapeutic use*; D013148:Spironolactone / Q000627:therapeutic use; D014223:Triamterene / Q000627:therapeutic use; D014882:Water-Electrolyte Balance / Q000187:drug effects
D000578:Amidines; D004232:Diuretics; D011719:Pyrazines; D006852:Hydrochlorothiazide; D013148:Spironolactone; D004976:Ethacrynic Acid; D014223:Triamterene